Tech Company Financing Transactions
DaltonTx Funding Round
DaltonTx, operating out of London, raised $5.3 million from IQ Capital Fund, Redalpine Venture and Seedcamp.
Transaction Overview
Company Name
Announced On
9/23/2025
Transaction Type
Venture Equity
Amount
$5,300,000
Round
Seed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
London, Undisclosed
UK
London, Undisclosed
UK
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
DaltonTx is redefining how technology powers drug discovery creating the intelligence engine behind tomorrow's medicines. Our adaptive AI platform provides pharma, biotech, and CROs with the intelligence backbone that modern R&D can't move forward without transforming the economics, timelines, and outcomes of discovery. Purpose-built for both small molecules and biologics, DaltonTx goes beyond predictive modelling to deliver a self-learning system that integrates seamlessly into scientific workflows and gets smarter with every experiment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Anthony Bradley
Co-Founder
Charlotte Deane
Co-Founder
Garry Pairaudeau
Co-Founder
Adrian Rossall
Browse more venture capital transactions:
Prev: 9/23/2025: Testkube venture capital transaction
Next: 9/23/2025: Genstore venture capital transaction
Share this article
About Database of VC Transactions
We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs